Krivak, T. C., Darcy, K. M., Tian, C., Armstrong, D., Baysal, B. E., Gallion, H., . . . DeLoia, J. A. (2008). Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer. J Clin Oncol.
Παραπομπή Chicago StyleKrivak, Thomas C., Kathleen M. Darcy, Chunqiao Tian, Deborah Armstrong, Bora E. Baysal, Holly Gallion, Christine B. Ambrosone, και Julie A. DeLoia. "Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer." J Clin Oncol 2008.
Παραπομπή MLAKrivak, Thomas C., et al. "Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer." J Clin Oncol 2008.